3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide

C117H96F19N43O14S7 — CID 159588387

IUPAC3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide
SMILESCCCc1ccc(-c2ccc(C3CCNCC3)cc2)c(C2=NCN=N2)c1S(N)(=O)=O.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(N)ccnc3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(N)n[nH]c3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3nccc(N)c3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc(N)c(F)c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc(N)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc3cc[nH]c3c2)c1-c1nn[nH]n1
InChIInChI=1S/C22H27N5O2S.2C18H13F3N6O2S.C16H12F3N7O2S.C16H11F3N6O2S.C14H10F4N6O2S.C13H10F3N7O2S/c1-2-3-18-8-9-19(20(21(18)30(23,28)29)22-25-14-26-27-22)17-6-4-15(5-7-17)16-10-12-24-13-11-16;1-30(28,29)16-12(18(19,20)21)4-3-10(15(16)17-24-26-27-25-17)9-2-5-14-11(8-9)13(22)6-7-23-14;1-30(28,29)16-12(18(19,20)21)5-4-10(15(16)17-24-26-27-25-17)9-2-3-11-13(22)6-7-23-14(11)8-9;1-29(27,28)13-10(16(17,18)19)5-4-8(12(13)15-23-25-26-24-15)7-2-3-9-11(6-7)21-22-14(9)20;1-28(26,27)14-10(16(17,18)19)3-2-9(13(14)15-22-24-25-23-15)8-6-12-11(21-7-8)4-5-20-12;1-27(25,26)11-8(14(16,17)18)3-2-7(10(11)13-21-23-24-22-13)6-4-9(15)12(19)20-5-6;1-26(24,25)10-8(13(14,15)16)3-2-7(6-4-18-12(17)19-5-6)9(10)11-20-22-23-21-11/h4-9,16,24H,2-3,10-14H2,1H3,(H2,23,28,29);2*2-8H,1H3,(H2,22,23)(H,24,25,26,27);2-6H,1H3,(H3,20,21,22)(H,23,24,25,26);2-7,20H,1H3,(H,22,23,24,25);2-5H,1H3,(H2,19,20)(H,21,22,23,24);2-5H,1H3,(H2,17,18,19)(H,20,21,22,23)
InChIKeyMJXQSSNGAGILIN-UHFFFAOYSA-N
MW2913.77 g/mol
LogP18.41
Rot. Bonds24

About 3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide

3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide (PubChem CID 159588387) has the molecular formula C117H96F19N43O14S7 and a molecular weight of 2913.77 g/mol. Its IUPAC name is 3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide.

Molecular Properties

Compound Name3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide
PubChem CID159588387
Molecular FormulaC117H96F19N43O14S7
Molecular Weight2913.77 g/mol
Exact Mass2911.59
IUPAC Name3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide
SMILESCCCc1ccc(-c2ccc(C3CCNCC3)cc2)c(C2=NCN=N2)c1S(N)(=O)=O.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(N)ccnc3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(N)n[nH]c3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3nccc(N)c3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc(N)c(F)c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc(N)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc3cc[nH]c3c2)c1-c1nn[nH]n1
InChIInChI=1S/C22H27N5O2S.2C18H13F3N6O2S.C16H12F3N7O2S.C16H11F3N6O2S.C14H10F4N6O2S.C13H10F3N7O2S/c1-2-3-18-8-9-19(20(21(18)30(23,28)29)22-25-14-26-27-22)17-6-4-15(5-7-17)16-10-12-24-13-11-16;1-30(28,29)16-12(18(19,20)21)4-3-10(15(16)17-24-26-27-25-17)9-2-5-14-11(8-9)13(22)6-7-23-14;1-30(28,29)16-12(18(19,20)21)5-4-10(15(16)17-24-26-27-25-17)9-2-3-11-13(22)6-7-23-14(11)8-9;1-29(27,28)13-10(16(17,18)19)5-4-8(12(13)15-23-25-26-24-15)7-2-3-9-11(6-7)21-22-14(9)20;1-28(26,27)14-10(16(17,18)19)3-2-9(13(14)15-22-24-25-23-15)8-6-12-11(21-7-8)4-5-20-12;1-27(25,26)11-8(14(16,17)18)3-2-7(10(11)13-21-23-24-22-13)6-4-9(15)12(19)20-5-6;1-26(24,25)10-8(13(14,15)16)3-2-7(6-4-18-12(17)19-5-6)9(10)11-20-22-23-21-11/h4-9,16,24H,2-3,10-14H2,1H3,(H2,23,28,29);2*2-8H,1H3,(H2,22,23)(H,24,25,26,27);2-6H,1H3,(H3,20,21,22)(H,23,24,25,26);2-7,20H,1H3,(H,22,23,24,25);2-5H,1H3,(H2,19,20)(H,21,22,23,24);2-5H,1H3,(H2,17,18,19)(H,20,21,22,23)
InChIKeyMJXQSSNGAGILIN-UHFFFAOYSA-N
XLogP18.41
TPSA892.78 Ų
H-Bond Donors15
H-Bond Acceptors48
Rotatable Bonds24
Heavy Atoms200
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002913.77
LogP ≤ 518.41
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1048

Analyze 3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide?
The IUPAC name of 3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide (CID 159588387) is 3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide.
What is the SMILES notation for 3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide?
The canonical SMILES for 3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide is CCCc1ccc(-c2ccc(C3CCNCC3)cc2)c(C2=NCN=N2)c1S(N)(=O)=O.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(N)ccnc3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(N)n[nH]c3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3nccc(N)c3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc(N)c(F)c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc(N)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc3cc[nH]c3c2)c1-c1nn[nH]n1.
What is the InChIKey of 3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide?
The InChIKey is MJXQSSNGAGILIN-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H27N5O2S.2C18H13F3N6O2S.C16H12F3N7O2S.C16H11F3N6O2S.C14H10F4N6O2S.C13H10F3N7O2S/c1-2-3-18-8-9-19(20(21(18)30(23,28)29)22-25-14-26-27-22)17-6-4-15(5-7-17)16-10-12-24-13-11-16;1-30(28,29)16-12(18(19,20)21)4-3-10(15(16)17-24-26-27-25-17)9-2-5-14-11(8-9)13(22)6-7-23-14;1-30(28,29)16-12(18(19,20)21)5-4-10(15(16)17-24-26-27-25-17)9-2-3-11-13(22)6-7-23-14(11)8-9;1-29(27,28)13-10(16(17,18)19)5-4-8(12(13)15-23-25-26-24-15)7-2-3-9-11(6-7)21-22-14(9)20;1-28(26,27)14-10(16(17,18)19)3-2-9(13(14)15-22-24-25-23-15)8-6-12-11(21-7-8)4-5-20-12;1-27(25,26)11-8(14(16,17)18)3-2-7(10(11)13-21-23-24-22-13)6-4-9(15)12(19)20-5-6;1-26(24,25)10-8(13(14,15)16)3-2-7(6-4-18-12(17)19-5-6)9(10)11-20-22-23-21-11/h4-9,16,24H,2-3,10-14H2,1H3,(H2,23,28,29);2*2-8H,1H3,(H2,22,23)(H,24,25,26,27);2-6H,1H3,(H3,20,21,22)(H,23,24,25,26);2-7,20H,1H3,(H,22,23,24,25);2-5H,1H3,(H2,19,20)(H,21,22,23,24);2-5H,1H3,(H2,17,18,19)(H,20,21,22,23).
What are the key properties of 3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide?
3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide has a molecular weight of 2913.77 g/mol, XLogP of 18.41, 24 rotatable bonds, 15 hydrogen bond donors, and 48 hydrogen bond acceptors.
Where does this data come from?
All data for 3-fluoro-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-indazol-3-amine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrimidin-2-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-4-amine;3-(4-piperidin-4-ylphenyl)-6-propyl-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide is sourced from PubChem (CID 159588387), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).